Immunization of preterm and low birth weight infants

被引:138
作者
Saari, TN [1 ]
机构
[1] AAP, Practice Action Grp, Elk Grove Village, IL 60007 USA
[2] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA
[3] Amer Acad Family Physicians, Leawood, KS 66211 USA
[4] NIH, Bethesda, MD 20892 USA
[5] Natl Vaccine Program Off, Atlanta, GA USA
[6] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA
[7] US FDA, Rockville, MD 20857 USA
[8] Amer Thorac Soc, New York, NY 10019 USA
关键词
D O I
10.1542/peds.112.1.193
中图分类号
R72 [儿科学];
学科分类号
100202 [儿科学];
摘要
Preterm (PT) infants are at increased risk of experiencing complications of vaccine-preventable diseases but are less likely to receive immunizations on time. Medically stable PT and low birth weight (LBW) infants should receive full doses of diphtheria, tetanus, acellular pertussis, Haemophilus influenzae type b, hepatitis B, poliovirus, and pneumococcal conjugate vaccines at a chronologic age consistent with the schedule recommended for full-term infants. Infants with birth weight less than 2000 g may require modification of the timing of hepatitis B immunoprophylaxis depending on maternal hepatitis B surface antigen status. All PT and LBW infants benefit from receiving influenza vaccine beginning at 6 months of age before the beginning of and during the influenza season. All vaccines routinely recommended during infancy are safe for use in PT and LBW infants. The occurrence of mild vaccine-attributable adverse events are similar in both full-term and PT vaccine recipients. Although the immunogenicity of some childhood vaccines may be decreased in the smallest PT infants, antibody concentrations achieved usually are protective.
引用
收藏
页码:193 / 198
页数:6
相关论文
共 44 条
[1]
Abramson JS, 2003, PEDIATRICS, V111, P212
[2]
SYSTEMIC AND LOCAL IMMUNE-RESPONSES TO ENHANCED-POTENCY INACTIVATED POLIOVIRUS VACCINE IN PREMATURE AND TERM INFANTS [J].
ADENYIJONES, SCA ;
FADEN, H ;
FERDON, MB ;
KWONG, MS ;
OGRA, PL .
JOURNAL OF PEDIATRICS, 1992, 120 (05) :686-689
[3]
*AM AC PED, 2000, 2000 RED BOOK REP CO, P54
[4]
*AM AC PED, 2003, RED BOOK 2003 REP CO, P66
[5]
*AM AC PED COMM IN, 1997, 1997 RED BOOK REP CO, P48
[6]
Immunogenicity of hepatitis B vaccine in term and preterm infants [J].
Belloni, C ;
Chirico, G ;
Pistorio, A ;
Orsolini, P ;
Tinelli, C ;
Rondini, G .
ACTA PAEDIATRICA, 1998, 87 (03) :336-338
[7]
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children [J].
Black, S ;
Shinefield, H ;
Fireman, B ;
Lewis, E ;
Ray, P ;
Hansen, JR ;
Elvin, L ;
Ensor, KM ;
Hackell, J ;
Siber, G ;
Malinoski, F ;
Madore, D ;
Chang, I ;
Kohberger, R ;
Watson, W ;
Austrian, R ;
Edwards, K .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (03) :187-195
[8]
Immunogenicity of hepatitis B vaccine in preterm infants [J].
Blondheim, O ;
Bader, D ;
Abend, M ;
Peniakov, M ;
Reich, D ;
Potesman, I ;
Handsher, R ;
Gidoni, I ;
Linder, N .
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1998, 79 (03) :F206-F208
[9]
Botham SJ, 1997, J PAEDIATR CHILD H, V33, P418, DOI 10.1111/j.1440-1754.1997.tb01632.x
[10]
Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1